In this episode, we explore how healthcare organizations can work with patient, consumer and HCP creators to build influence ...
PBMs were conceived as a way to manage prescriptions and hold down costs. But these middlemen have become bipartisan punching ...
FDA approves Lilly’s weekly insulin shot; Study finds tobacco industry spammed FDA comments opposing menthol cigarette ban; ...
The run-up to the midterm elections is turning into a food fight — literally. The summer was marred by a massive foodborne ...
The FDA approved Ultragenyx Pharmaceutical’s Fayuvi (rebisufligene etisparvovec-hopf), the first treatment for children with ...
The multiyear deal embeds real-time pricing into Epocrates' drug content. Executives call the launch a baseline and pitch it ...
Trust in the pharma industry has been steadily declining among consumers, regardless of political affiliation. A 2023 study ...
For Hispanic Heritage Month, marketing leaders from Cologuard and MetroPlusHealth explain why culturally relevant healthcare ...
Voters will weigh in on abortion in Missouri, and three other states, in the November general election. Missouri is also one ...
The drugmaker designed “Because Ibsrela Can” with clear, static safety visuals after studying the agency’s recent objections ...
Moran referred to “change fatigue” at a morning panel that also featured 2025 MM+M Awards jury chair Meghan Rivera, VP, ...
AstraZeneca’s campaign supporting its asthma and COPD treatment Breztri features several AI-generated elements.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results